Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-07-03 Sale |
2025-07-08 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer |
1,477 | $2.882 | $4,257 | 128,173 (Direct) |
View |
| 2025-05-20 Sale |
2025-05-22 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
357 | $6.446 | $2,301 | 64,027 (Direct) |
View |
| 2025-05-20 Sale |
2025-05-22 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
801 | $6.446 | $5,163 | 235,255 (Direct) |
View |
| 2025-05-20 Sale |
2025-05-22 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
767 | $6.446 | $4,944 | 573,628 (Indirect Direct) |
View |
| 2025-05-20 Sale |
2025-05-22 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
2,253 | $6.446 | $14,523 | 1,193,044 (Indirect Direct) |
View |
| 2025-05-20 Sale |
2025-05-22 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
587 | $6.446 | $3,784 | 149,163 (Direct) |
View |
| 2025-05-16 Sale |
2025-05-20 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
655 | $6.528 | $4,276 | 64,384 (Direct) |
View |
| 2025-05-16 Sale |
2025-05-20 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,409 | $6.528 | $9,198 | 574,395 (Indirect Direct) |
View |
| 2025-05-16 Sale |
2025-05-20 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
1,582 | $6.528 | $10,327 | 236,056 (Direct) |
View |
| 2025-05-16 Sale |
2025-05-20 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
3,621 | $6.528 | $23,638 | 1,195,297 (Indirect Direct) |
View |
| 2025-05-16 Sale |
2025-05-20 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
946 | $6.528 | $6,175 | 149,750 (Direct) |
View |
| 2025-04-22 Sale |
2025-04-24 4:06 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
718 | $7.158 | $5,139 | 65,039 (Direct) |
View |
| 2025-04-10 Purchase |
2025-04-14 6:57 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
20,000 | $5.08 | $101,600 | 1,198,918 (Indirect Direct) |
View |
| 2025-04-09 Purchase |
2025-04-10 4:07 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
21,099 | $4.7 | $99,165 | 575,804 (Indirect Direct) |
View |
| 2025-04-04 Sale |
2025-04-08 4:06 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer |
7,489 | $5.294 | $39,647 | 129,650 (Direct) |
View |
| 2024-05-17 Sale |
2025-02-27 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
15,093 | $14.84 | $223,965 | 237,638 (Direct) |
View |
| 2025-02-21 Sale |
2025-02-25 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
6,078 | $10.58 | $64,305 | 554,705 (Indirect Direct) |
View |
| 2025-02-21 Sale |
2025-02-25 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
3,222 | $10.58 | $34,089 | 150,696 (Direct) |
View |
| 2025-02-21 Sale |
2025-02-25 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,737 | $10.58 | $28,957 | 65,757 (Direct) |
View |
| 2025-02-21 Sale |
2025-02-25 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
16,303 | $10.58 | $172,486 | 1,178,918 (Indirect Direct) |
View |
| 2025-01-23 Sale |
2025-01-27 4:16 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
896 | $10.38 | $9,300 | 48,414 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
54,734 | $0 | 54,734 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director |
30,000 | $0 | 44,220 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
47,667 | $0 | 18,236,124 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
49,434 | $0 | 1,036,846 (Indirect) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-06-18 Option Award |
2025-07-18 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
30,000 | $0 | 144,784 (Direct) |
View |
| 2025-03-05 Other |
2025-04-24 4:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director |
14,220 | $0 | 28,440 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
225,000 | $0 | 288,560 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
325,000 | $0 | 1,438,566 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2025-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
200,000 | $0 | 372,413 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
230,000 | $0 | 732,997 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer |
225,000 | $0 | 271,781 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2035-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
50,000 | $0 | 98,414 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:47 pm |
N/A 2035-02-03 |
ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director |
73,624 | $0 | 73,624 (Direct) |
View |
Ownership |
2025-02-05 7:43 pm |
2020-08-03 2030-08-03 |
ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director |
0 | $0 | 20,000 (Direct) |
View |